Philadelphia Trust Company’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Philadelphia Trust Company’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-5,800	Closed	-$562K	–	203
2019 Q3	$562K	Hold	5,800	–	–	0.05%	152
2019 Q2	$594K	Hold	5,800	–	–	0.05%	148
2019 Q1	$661K	Buy	+5,800	New	+$426K	0.06%	138
2018 Q4	–	Sell	-5,800	Closed	-$316K	–	202
2018 Q3	$316K	Hold	5,800	–	–	0.03%	173
2018 Q2	$480K	Hold	5,800	–	–	0.04%	151
2018 Q1	$386K	Hold	5,800	–	–	0.03%	166
2017 Q4	$298K	Hold	5,800	–	–	0.02%	193
2017 Q3	$517K	Hold	5,800	–	–	0.04%	150
2017 Q2	$346K	Hold	5,800	–	–	0.03%	175
2017 Q1	$309K	Buy	+5,800	New	+$344K	0.03%	189

Philadelphia Trust Company's ONCE Position: Q4 2019 in Review

Philadelphia Trust Company sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 5,800 shares — an estimated $562K sold.

Philadelphia Trust Company first reported a position in ONCE in Q1 2017 and held it in 10 quarters. The position peaked at $661K in Q1 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

Philadelphia Trust Company reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Philadelphia Trust Company sold 5,800 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $562K.
Philadelphia Trust Company first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2017 and held it in 10 quarters.
Philadelphia Trust Company's Spark Therapeutics, Inc. Common Stock position peaked at $661K in Q1 2019.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Philadelphia Trust Company's 13F filing for Q4 2019, filed 10 Feb 2020.